The invention discloses a
traditional Chinese medicine composition for treating chronic virulent
hepatitis b and a preparation method thereof, and belongs to the technical field of
Chinese patent medicine for treating
hepatitis b. According to the technical scheme, the
traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 55-72 parts of
astragalus membranaceus, 58-75 parts of
salvia miltiorrhiza, 40-56 parts of glossy
privet fruit, 40-58 parts of Chinese wolfberry, 40-58 parts of rhizoma smilacis glabrae, 30-52 parts of
radix bupleuri, 32-48 parts of poria cocos, 30-52 parts of
schisandra chinensis, 30-58 parts of
codonopsis pilosula, 28-56 parts of
pinellia ternate, 28-58 parts of Chinese yam, 30-46 parts of
isatis roots, 32-48 parts of bighead atractylodes
rhizome, 30-46 parts of
curcuma aromatica, 32-46 parts of radix paeoniae alba, 30-49 parts of
oldenlandia diffusa, 32-49 parts of
angelica sinensis, 35-46 parts of
pericarpium citri reticulatae, 35-50 parts of
honeysuckle, 30-44 parts of
polygonatum sibiricum and 25-35 parts of
coke hawthorn. The invention further discloses the preparation method for the
traditional Chinese medicine composition for treating chronic virulent
hepatitis b. The traditional Chinese
medicine composition is prepared from traditional Chinese medicinal materials, has no toxic or
side effect, and is low in cost. Animal experiments and clinical application studies find that the traditional Chinese
medicine composition has good anti-HBV activity.